PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study (Q37130814)

18 August 2017

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Lars Maegdefessel

8

0 references

Uwe Raaz

9

object named as

Uwe Raaz

1 reference

18 August 2017

Axel Schlitt

1

1 reference

18 August 2017

Stefan Blankenberg

2

1 reference

18 August 2017

Christoph Bickel

3

1 reference

18 August 2017

Karl J Lackner

4

1 reference

18 August 2017

Gunnar H Heine

5

1 reference

18 August 2017

Michael Buerke

6

1 reference

18 August 2017

Karl Werdan

7

1 reference

18 August 2017

Hans J Rupprecht

10

1 reference

18 August 2017

Thomas Munzel

11

1 reference

18 August 2017

Xian-Cheng Jiang

12

1 reference

18 August 2017

10 November 2008

1 reference

Journal of Lipid Research

18 August 2017

1 reference

18 August 2017

50

1 reference

18 August 2017

4

1 reference

18 August 2017

723-729

1 reference

Plaque stabilization: Can we turn theory into evidence?

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Current perspectives on statins

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

The pathogenesis of atherosclerosis: a perspective for the 1990s

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

The response-to-retention hypothesis of early atherogenesis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Role of oxidized low density lipoprotein in atherogenesis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Statins of different brain penetrability differentially affect CSF PLTP activity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656666

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1194%2FJLR.M800414-JLR200

Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity

21 January 2018

1 reference

12 December 2020

Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive

1 reference

12 December 2020

Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency

1 reference

12 December 2020

Plasma Phospholipid Transfer Protein Activity Is Decreased in Type 2 Diabetes During Treatment With Atorvastatin: A Role for Apolipoprotein E?

1 reference

12 December 2020

Phospholipid transfer protein in hemodialysis patients

1 reference

12 December 2020

Phospholipid transfer protein-deficient mice absorb less cholesterol

1 reference

12 December 2020

Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis

1 reference

12 December 2020

Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin

1 reference

12 December 2020

High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease

1 reference

12 December 2020

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity

1 reference

12 December 2020

Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue

1 reference

12 December 2020

Human plasma phospholipid transfer protein causes high density lipoprotein conversion

1 reference

12 December 2020

High density lipoprotein conversion mediated by human plasma phospholipid transfer protein

1 reference

12 December 2020

Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL

1 reference

12 December 2020

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin

1 reference

12 December 2020

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins

1 reference

12 December 2020

10.1194/JLR.M800414-JLR200

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19001358

1 reference